We tried Martha Stewart’s Elm Biosciences skincare — including her ‘luxurious’ new night cream

So we were immediately intrigued when she launched her own skincare line, Elm Biosciences, in late 2025 with two products: ...

15 Best Anti-Wrinkle Serums for Smoother Skin, According to Dermatologists and Testing

These top-rated anti-aging serums help improve the look of wrinkles, fine lines, and more. Getting wrinkles, fine lines, and ...
Glamour

How to Apply Lash Serum for Longer, Healthier Eyelashes

What are lash serums and how do they work? “Lash serums are topical treatments that are applied to your eyelashes to enhance ...
Glamour

How to Apply Curl Cream for Bouncy, Hydrated Hair

A great curl cream can make a world of difference in your curly hair routine—that is, if you know how to apply curl cream correctly. These styling products (intended for coily, curly, and wavy hair ...
Seeking Alpha

FDA Accepts Supplemental New Drug Application for Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026 If approved, ZORYVE cream 0.3% would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in ...
oprahdaily

How to Find the Best Estrogen Face Cream During Menopause

Our editors handpick the products that we feature. We may earn commission from the links on this page. On the upside, there’s topical estrogen (the two most common forms are estriol and the more ...
Morningstar

LEO Pharma continues global rollout of Anzupgo® (delgocitinib) cream with submission of New Drug Application in China

LEO Pharma A/S, a global leader in medical dermatology, has today announced submission of the New Drug Application (NDA) to the National Medical Products Administration (NMPA) in China for Anzupgo® ...
Nasdaq

Arcutis Submits Supplemental New Drug Application for ZORYVE® (roflumilast) Cream 0.3% to Expand Indication for Treatment of Plaque Psoriasis in Children Ages 2 to 5

WESTLAKE VILLAGE, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in ...